Compile Data Set for Download or QSAR
Found 36 with Last Name = 'berman' and Initial = 'jm'
TargetGastrin/cholecystokinin type B receptor(Homo sapiens (Human))
Glaxo Wellcome

Curated by ChEMBL
LigandPNGBDBM21147((3S)-3-[(2S)-2-[(2S)-2-{2-[(2S)-2-[(2S)-2-[(3S)-3-...)copy SMILEScopy InChI
Affinity DataIC50: 0.320nMAssay Description:Concentration required to displace [125I]Bolton-Hunter CCK-8 from human Cholecystokinin type B receptor stably expressed in CHO-K1 cellsMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q22R3SZ1PubMed
TargetEnoyl-[acyl-carrier-protein] reductase [NADH] FabI(Escherichia coli)
Affinium Pharmaceuticals Inc.

Curated by ChEMBL
LigandPNGBDBM50481111(CHEMBL566647)copy SMILEScopy InChI
Affinity DataIC50: 0.400nMAssay Description:Inhibition of Escherichia coli FabI assessed as effect on NAD(P)H consumptionMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q21G0Q2BPubMed
TargetCholecystokinin receptor type A(Homo sapiens (Human))
Glaxo Wellcome

Curated by ChEMBL
LigandPNGBDBM21147((3S)-3-[(2S)-2-[(2S)-2-{2-[(2S)-2-[(2S)-2-[(3S)-3-...)copy SMILEScopy InChI
Affinity DataIC50: 0.630nMAssay Description:Concentration required to displace [125I]Bolton-Hunter CCK-8 from human Cholecystokinin type A receptor stably expressed in CHO-K1 cellsMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q22R3SZ1PubMed
TargetEnoyl-[acyl-carrier-protein] reductase [NADH] FabI(Escherichia coli)
Affinium Pharmaceuticals Inc.

Curated by ChEMBL
LigandPNGBDBM50481110(CHEMBL586043)copy SMILEScopy InChI
Affinity DataIC50: 0.700nMAssay Description:Inhibition of Escherichia coli FabI assessed as effect on NAD(P)H consumptionMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q21G0Q2BPubMed
TargetEnoyl-[acyl-carrier-protein] reductase [NADH] FabI(Escherichia coli)
Affinium Pharmaceuticals Inc.

Curated by ChEMBL
LigandPNGBDBM50481112(CHEMBL567711)copy SMILEScopy InChI
Affinity DataIC50: 1.80nMAssay Description:Inhibition of Escherichia coli FabI assessed as effect on NAD(P)H consumptionMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q21G0Q2BPubMed
TargetEnoyl-[acyl-carrier-protein] reductase [NADH] FabI(Escherichia coli)
Affinium Pharmaceuticals Inc.

Curated by ChEMBL
LigandPNGBDBM50481108(CHEMBL566665)copy SMILEScopy InChI
Affinity DataIC50: 2.40nMAssay Description:Inhibition of Escherichia coli FabI assessed as effect on NAD(P)H consumptionMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q21G0Q2BPubMed
TargetEnoyl-[acyl-carrier-protein] reductase [NADH] FabI(Escherichia coli)
Affinium Pharmaceuticals Inc.

Curated by ChEMBL
LigandPNGBDBM50481114(CHEMBL566043)copy SMILEScopy InChI
Affinity DataIC50: 7nMAssay Description:Inhibition of Escherichia coli FabI assessed as effect on NAD(P)H consumptionMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q21G0Q2BPubMed
TargetEnoyl-[acyl-carrier-protein] reductase [NADPH] FabI(Staphylococcus aureus)
Affinium Pharmaceuticals Inc.

Curated by ChEMBL
LigandPNGBDBM50481108(CHEMBL566665)copy SMILEScopy InChI
Affinity DataIC50: 14nMAssay Description:Inhibition of Staphylococcus aureus FabIMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q21G0Q2BPubMed
TargetGastrin/cholecystokinin type B receptor(Homo sapiens (Human))
Glaxo Wellcome

Curated by ChEMBL
LigandPNGBDBM50422155(CHEMBL443825)copy SMILEScopy InChI
Affinity DataIC50: 16nMAssay Description:Concentration required to displace [125I]Bolton-Hunter CCK-8 from human Cholecystokinin type B receptor expressed in CHO-K1 cellsMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q22R3SZ1PubMed
TargetEnoyl-[acyl-carrier-protein] reductase [NADH] FabI(Escherichia coli)
Affinium Pharmaceuticals Inc.

Curated by ChEMBL
LigandPNGBDBM50481106(CHEMBL571088)copy SMILEScopy InChI
Affinity DataIC50: 17nMAssay Description:Inhibition of Escherichia coli FabI assessed as effect on NAD(P)H consumptionMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q21G0Q2BPubMed
TargetEnoyl-[acyl-carrier-protein] reductase [NADPH] FabI(Staphylococcus aureus)
Affinium Pharmaceuticals Inc.

Curated by ChEMBL
LigandPNGBDBM50481112(CHEMBL567711)copy SMILEScopy InChI
Affinity DataIC50: 20nMAssay Description:Inhibition of Staphylococcus aureus FabIMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q21G0Q2BPubMed
TargetEnoyl-[acyl-carrier-protein] reductase [NADH] FabI(Escherichia coli)
Affinium Pharmaceuticals Inc.

Curated by ChEMBL
LigandPNGBDBM50481109(CHEMBL566666)copy SMILEScopy InChI
Affinity DataIC50: 24nMAssay Description:Inhibition of Escherichia coli FabI assessed as effect on NAD(P)H consumptionMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q21G0Q2BPubMed
TargetGastrin/cholecystokinin type B receptor(Homo sapiens (Human))
Glaxo Wellcome

Curated by ChEMBL
LigandPNGBDBM50072427(1-(1-(2-(isopropyl(phenyl)amino)-2-oxoethyl)-2,4-d...)copy SMILEScopy InChI
Affinity DataIC50: 25nMAssay Description:Concentration required to displace [125I]Bolton-Hunter CCK-8 from human Cholecystokinin type B receptor expressed in CHO-K1 cellsMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q22R3SZ1PubMed
TargetEnoyl-[acyl-carrier-protein] reductase [NADPH] FabI(Staphylococcus aureus)
Affinium Pharmaceuticals Inc.

Curated by ChEMBL
LigandPNGBDBM50481113(CHEMBL568359)copy SMILEScopy InChI
Affinity DataIC50: 26nMAssay Description:Inhibition of Staphylococcus aureus FabIMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q21G0Q2BPubMed
TargetEnoyl-[acyl-carrier-protein] reductase [NADPH] FabI(Staphylococcus aureus)
Affinium Pharmaceuticals Inc.

Curated by ChEMBL
LigandPNGBDBM50481114(CHEMBL566043)copy SMILEScopy InChI
Affinity DataIC50: 26nMAssay Description:Inhibition of Staphylococcus aureus FabIMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q21G0Q2BPubMed
TargetEnoyl-[acyl-carrier-protein] reductase [NADPH] FabI(Staphylococcus aureus)
Affinium Pharmaceuticals Inc.

Curated by ChEMBL
LigandPNGBDBM50481109(CHEMBL566666)copy SMILEScopy InChI
Affinity DataIC50: 28nMAssay Description:Inhibition of Staphylococcus aureus FabIMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q21G0Q2BPubMed
TargetEnoyl-[acyl-carrier-protein] reductase [NADPH] FabI(Staphylococcus aureus)
Affinium Pharmaceuticals Inc.

Curated by ChEMBL
LigandPNGBDBM50481092(CHEMBL566655)copy SMILEScopy InChI
Affinity DataIC50: 30nMAssay Description:Inhibition of Staphylococcus aureus FabIMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q21G0Q2BPubMed
TargetGastrin/cholecystokinin type B receptor(Homo sapiens (Human))
Glaxo Wellcome

Curated by ChEMBL
LigandPNGBDBM50422157(CHEMBL345786)copy SMILEScopy InChI
Affinity DataIC50: 32nMAssay Description:Concentration required to displace [125I]Bolton-Hunter CCK-8 from human Cholecystokinin type B receptor expressed in CHO-K1 cellsMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q22R3SZ1PubMed
TargetGastrin/cholecystokinin type B receptor(Homo sapiens (Human))
Glaxo Wellcome

Curated by ChEMBL
LigandPNGBDBM50422156(CHEMBL346179)copy SMILEScopy InChI
Affinity DataIC50: 40nMAssay Description:Concentration required to displace [125I]Bolton-Hunter CCK-8 from human Cholecystokinin type B receptor expressed in CHO-K1 cellsMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q22R3SZ1PubMed
TargetCholecystokinin receptor type A(Homo sapiens (Human))
Glaxo Wellcome

Curated by ChEMBL
LigandPNGBDBM50422155(CHEMBL443825)copy SMILEScopy InChI
Affinity DataIC50: 40nMAssay Description:Concentration required to displace [125I]Bolton-Hunter CCK-8 from human Cholecystokinin type A receptor stably expressed in CHO-K1 cellsMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q22R3SZ1PubMed
TargetEnoyl-[acyl-carrier-protein] reductase [NADPH] FabI(Staphylococcus aureus)
Affinium Pharmaceuticals Inc.

Curated by ChEMBL
LigandPNGBDBM50481111(CHEMBL566647)copy SMILEScopy InChI
Affinity DataIC50: 48nMAssay Description:Inhibition of Staphylococcus aureus FabIMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q21G0Q2BPubMed
TargetEnoyl-[acyl-carrier-protein] reductase [NADPH] FabI(Staphylococcus aureus)
Affinium Pharmaceuticals Inc.

Curated by ChEMBL
LigandPNGBDBM50481110(CHEMBL586043)copy SMILEScopy InChI
Affinity DataIC50: 49nMAssay Description:Inhibition of Staphylococcus aureus FabIMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q21G0Q2BPubMed
TargetGastrin/cholecystokinin type B receptor(Homo sapiens (Human))
Glaxo Wellcome

Curated by ChEMBL
LigandPNGBDBM50072425(2-[2,4-Dioxo-5-phenyl-3-(3-phenyl-ureido)-2,3,4,5-...)copy SMILEScopy InChI
Affinity DataIC50: 50nMAssay Description:Concentration required to displace [125I]Bolton-Hunter CCK-8 from human Cholecystokinin type B receptor expressed in CHO-K1 cellsMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q22R3SZ1PubMed
TargetCholecystokinin receptor type A(Homo sapiens (Human))
Glaxo Wellcome

Curated by ChEMBL
LigandPNGBDBM50072427(1-(1-(2-(isopropyl(phenyl)amino)-2-oxoethyl)-2,4-d...)copy SMILEScopy InChI
Affinity DataIC50: 50nMAssay Description:Concentration required to displace [125I]Bolton-Hunter CCK-8 from human Cholecystokinin type A receptor stably expressed in CHO-K1 cellsMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q22R3SZ1PubMed
TargetEnoyl-[acyl-carrier-protein] reductase [NADPH] FabI(Staphylococcus aureus)
Affinium Pharmaceuticals Inc.

Curated by ChEMBL
LigandPNGBDBM8732((2E)-N-methyl-N-[(1-methyl-1H-indol-2-yl)methyl]-3...)copy SMILEScopy InChI
Affinity DataIC50: 50nMAssay Description:Inhibition of Staphylococcus aureus FabIMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q21G0Q2BPubMed
TargetEnoyl-[acyl-carrier-protein] reductase [NADH] FabI(Escherichia coli)
Affinium Pharmaceuticals Inc.

Curated by ChEMBL
LigandPNGBDBM50481113(CHEMBL568359)copy SMILEScopy InChI
Affinity DataIC50: 55nMAssay Description:Inhibition of Escherichia coli FabI assessed as effect on NAD(P)H consumptionMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q21G0Q2BPubMed
TargetCholecystokinin receptor type A(Homo sapiens (Human))
Glaxo Wellcome

Curated by ChEMBL
LigandPNGBDBM50422153(CHEMBL345869)copy SMILEScopy InChI
Affinity DataIC50: 63nMAssay Description:Concentration required to displace [125I]Bolton-Hunter CCK-8 from human Cholecystokinin type A receptor stably expressed in CHO-K1 cellsMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q22R3SZ1PubMed
TargetEnoyl-[acyl-carrier-protein] reductase [NADPH] FabI(Staphylococcus aureus)
Affinium Pharmaceuticals Inc.

Curated by ChEMBL
LigandPNGBDBM50481107(CHEMBL565827)copy SMILEScopy InChI
Affinity DataIC50: 71nMAssay Description:Inhibition of Staphylococcus aureus FabIMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q21G0Q2BPubMed
TargetCholecystokinin receptor type A(Homo sapiens (Human))
Glaxo Wellcome

Curated by ChEMBL
LigandPNGBDBM50072425(2-[2,4-Dioxo-5-phenyl-3-(3-phenyl-ureido)-2,3,4,5-...)copy SMILEScopy InChI
Affinity DataIC50: 79nMAssay Description:Concentration required to displace [125I]Bolton-Hunter CCK-8 from human Cholecystokinin type A receptor stably expressed in CHO-K1 cellsMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q22R3SZ1PubMed
TargetCholecystokinin receptor type A(Homo sapiens (Human))
Glaxo Wellcome

Curated by ChEMBL
LigandPNGBDBM50422157(CHEMBL345786)copy SMILEScopy InChI
Affinity DataIC50: 100nMAssay Description:Concentration required to displace [125I]Bolton-Hunter CCK-8 from human Cholecystokinin type A receptor stably expressed in CHO-K1 cellsMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q22R3SZ1PubMed
TargetEnoyl-[acyl-carrier-protein] reductase [NADPH] FabI(Staphylococcus aureus)
Affinium Pharmaceuticals Inc.

Curated by ChEMBL
LigandPNGBDBM50481106(CHEMBL571088)copy SMILEScopy InChI
Affinity DataIC50: 132nMAssay Description:Inhibition of Staphylococcus aureus FabIMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q21G0Q2BPubMed
TargetEnoyl-[acyl-carrier-protein] reductase [NADH] FabI(Escherichia coli)
Affinium Pharmaceuticals Inc.

Curated by ChEMBL
LigandPNGBDBM8732((2E)-N-methyl-N-[(1-methyl-1H-indol-2-yl)methyl]-3...)copy SMILEScopy InChI
Affinity DataIC50: 139nMAssay Description:Inhibition of Escherichia coli FabI assessed as effect on NAD(P)H consumptionMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q21G0Q2BPubMed
TargetGastrin/cholecystokinin type B receptor(Homo sapiens (Human))
Glaxo Wellcome

Curated by ChEMBL
LigandPNGBDBM50422154(CHEMBL154615)copy SMILEScopy InChI
Affinity DataIC50: 158nMAssay Description:Concentration required to displace [125I]Bolton-Hunter CCK-8 from human Cholecystokinin type B receptor expressed in CHO-K1 cellsMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q22R3SZ1PubMed
TargetGastrin/cholecystokinin type B receptor(Homo sapiens (Human))
Glaxo Wellcome

Curated by ChEMBL
LigandPNGBDBM50422153(CHEMBL345869)copy SMILEScopy InChI
Affinity DataIC50: 251nMAssay Description:Concentration required to displace [125I]Bolton-Hunter CCK-8 from human Cholecystokinin type B receptor expressed in CHO-K1 cellsMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q22R3SZ1PubMed
TargetCholecystokinin receptor type A(Homo sapiens (Human))
Glaxo Wellcome

Curated by ChEMBL
LigandPNGBDBM50422154(CHEMBL154615)copy SMILEScopy InChI
Affinity DataIC50: 2.00E+3nMAssay Description:Concentration required to displace [125I]Bolton-Hunter CCK-8 from human Cholecystokinin type A receptor stably expressed in CHO-K1 cellsMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q22R3SZ1PubMed
TargetCholecystokinin receptor type A(Homo sapiens (Human))
Glaxo Wellcome

Curated by ChEMBL
LigandPNGBDBM50422156(CHEMBL346179)copy SMILEScopy InChI
Affinity DataIC50: 2.51E+3nMAssay Description:Concentration required to displace [125I]Bolton-Hunter CCK-8 from human Cholecystokinin type A receptor stably expressed in CHO-K1 cellsMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q22R3SZ1PubMed